Van 't Hoff Institute for Molecular Sciences (HIMS), Science Park 904, 1098 XH, Amsterdam, The Netherlands.
Enzypep B.V., Urmonderbaan 22, 6167 RD, Geleen, The Netherlands.
Chembiochem. 2018 Sep 17;19(18):1934-1938. doi: 10.1002/cbic.201800346. Epub 2018 Aug 2.
A broadly applicable one-pot methodology for the facile transformation of linear peptides into tetracyclic peptides through a chemoenzymatic peptide synthesis/chemical ligation of peptides onto scaffolds/copper(I)-catalyzed reaction (CEPS/CLIPS/CuAAC; "triple-C") locking methodology is reported. Linear peptides with varying lengths (≥14 amino acids), comprising two cysteines and two azidohomoalanines (Aha), were efficiently cyclized head-to-tail by using the peptiligase variant omniligase-1 (CEPS). Subsequent ligation-cyclization with tetravalent (T4 ) scaffolds containing two bromomethyl groups (CLIPS) and two alkyne functionalities (CuAAC) yielded isomerically pure tetracyclic peptides. Sixteen different functional tetracycles, derived from bicyclic inhibitors against urokinase plasminogen activator (uPA) and coagulation factor XIIa (FXIIa), were successfully synthesized and their bioactivities evaluated. Two of these (FF-T4 ) exhibited increased inhibitory activity against FXIIa, compared with a bicyclic control peptide. The corresponding hetero-bifunctional variants (UF/FU-T4 ), with a single copy of each inhibitory sequence, exhibited micromolar activities against both uPA and FXIIa; thus illustrating the potential of the "bifunctional tetracyclic peptide" inhibitor concept.
本文报道了一种广泛适用的一锅法策略,通过化学酶促肽合成/肽在支架上的化学连接/铜(I)催化反应(CEPS/CLIPS/CuAAC;“三重-C”)锁合方法,将线性肽轻松转化为四环肽。使用变体肽连接酶 omniligase-1(CEPS),可以有效地将具有不同长度(≥14 个氨基酸)的线性肽进行头尾环化,该线性肽包含两个半胱氨酸和两个叠氮高丙氨酸(Aha)。随后与含有两个溴甲基(CLIPS)和两个炔基官能团(CuAAC)的四价(T4)支架进行连接-环化,得到异构纯的四环肽。成功合成了来自纤溶酶原激活剂(uPA)和凝血因子 XIIa(FXIIa)双环抑制剂的十六种不同功能的四环肽,并对其生物活性进行了评估。其中两种(FF-T4)对 FXIIa 的抑制活性增强,与双环对照肽相比。具有每个抑制序列单个拷贝的相应杂双功能变体(UF/FU-T4)对 uPA 和 FXIIa 均表现出微摩尔级的活性;因此说明了“双功能四环肽”抑制剂概念的潜力。